| Transcripts of the Prostate Cancer-Associated Gene ANO7 Are Retained in the Nuclei of Prostatic Epithelial Cells. | Transcripts of the Prostate Cancer-Associated Gene ANO7 Are Retained in the Nuclei of Prostatic Epithelial Cells.
Metsälä O, Wahlström G, Taimen P, Kellokumpu-Lehtinen PL, Schleutker J., Free PMC Article | 01/28/2023 |
| The variant rs77559646 associated with aggressive prostate cancer disrupts ANO7 mRNA splicing and protein expression. | The variant rs77559646 associated with aggressive prostate cancer disrupts ANO7 mRNA splicing and protein expression.
Wahlström G, Heron S, Knuuttila M, Kaikkonen E, Tulonen N, Metsälä O, Löf C, Ettala O, Boström PJ, Taimen P, Poutanen M, Schleutker J., Free PMC Article | 07/2/2022 |
| Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer. | Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer.
Marx A, Koopmann L, Höflmayer D, Büscheck F, Hube-Magg C, Steurer S, Eichenauer T, Clauditz TS, Wilczak W, Simon R, Sauter G, Izbicki JR, Huland H, Heinzer H, Graefen M, Haese A, Schlomm T, Bernreuther C, Lebok P, Bonk S., Free PMC Article | 12/18/2021 |
| The interactome of the prostate-specific protein Anoctamin 7. | The interactome of the prostate-specific protein Anoctamin 7.
Kaikkonen E, Takala A, Pursiheimo JP, Wahlström G, Schleutker J., Free PMC Article | 02/6/2021 |
| ANO7 genotypes correlate with expression and biochemical relapse, suggesting that ANO7 is a potential PrCa susceptibility gene and that its elevated expression correlates with disease severity and outcome. | ANO7 is associated with aggressive prostate cancer.
Kaikkonen E, Rantapero T, Zhang Q, Taimen P, Laitinen V, Kallajoki M, Jambulingam D, Ettala O, Knaapila J, Boström PJ, Wahlström G, Sipeky C, Pursiheimo JP, Tammela T, Kellokumpu-Lehtinen PL, PRACTICAL Consortium, Fey V, Maehle L, Wiklund F, Wei GH, Schleutker J., Free PMC Article | 03/9/2019 |
| high level of NGEP expression could be associated with good prognosis in prostate cancer | Study of NGEP expression pattern in cancerous tissues provides novel insights into prognostic marker in prostate cancer.
Mohsenzadegan M, Shekarabi M, Madjd Z, Asgari M, Abolhasani M, Tajik N, Farajollahi MM. | 01/16/2016 |
| NGEP protein is widely expressed in low-grade to high-grade prostate adenocarcinomas as well as benign prostate tissues, and the intensity of expression is inversely proportional to the level of malignancy. | Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis.
Mohsenzadegan M, Madjd Z, Asgari M, Abolhasani M, Shekarabi M, Taeb J, Shariftabrizi A., Free PMC Article | 05/10/2014 |
| NGEP is a potential target for T cell-mediated immunotherapy of prostate cancer. | New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy.
Cereda V, Poole DJ, Palena C, Das S, Bera TK, Remondo C, Gulley JL, Arlen PM, Yokokawa J, Pastan I, Schlom J, Tsang KY., Free PMC Article | 01/21/2010 |
| NGEP is a glycoprotein with predicted glycosylation sites at N809 and N824. When these residues were converted to glutamine, glycosylation was abolished, confirming that the residues are extracellular | Topology of NGEP, a prostate-specific cell:cell junction protein widely expressed in many cancers of different grade level.
Das S, Hahn Y, Walker DA, Nagata S, Willingham MC, Peehl DM, Bera TK, Lee B, Pastan I., Free PMC Article | 01/21/2010 |
| expressed only in prostate and prostate camcer is a promising target for the antibody-based therapies of prostate cancer | NGEP, a gene encoding a membrane protein detected only in prostate cancer and normal prostate.
Bera TK, Das S, Maeda H, Beers R, Wolfgang CD, Kumar V, Hahn Y, Lee B, Pastan I., Free PMC Article | 01/21/2010 |
| Complete coding sequence of TMEM16G cDNA was determined by assembling 25 exons of TMEM16G gene | Characterization of human TMEM16G gene in silico.
Katoh M, Katoh M. | 01/21/2010 |
| description of the novel prostate-restricted molecule D-TMPP widely expressed in prostate cancer tissues | D-TMPP: a novel androgen-regulated gene preferentially expressed in prostate and prostate cancer that is the first characterized member of an eukaryotic gene family.
Kiessling A, Weigle B, Fuessel S, Ebner R, Meye A, Rieger MA, Schmitz M, Temme A, Bachmann M, Wirth MP, Rieber EP. | 01/21/2010 |